Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 30, 2024

Novel Prognostic Scoring Systems for Severe CRS and ICANS After Anti-CD19 CAR T Cells for LBCL

Journal of Hematology & Oncology

 

Additional Info

Journal of Hematology & Oncology
Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma
J Hematol Oncol 2024 Aug 06;17(1)61, P Sesques, AA Kirkwood, M Kwon, K Rejeski, MD Jain, R Di Blasi, G Brisou, FX Gros, F le Bras, P Bories, S Choquet, MT Rubio, G Iacoboni, M O'Reilly, RO Casasnovas, JO Bay, M Mohty, M Joris, J Abraham, C Castilla Llorente, M Loschi, S Carras, A Chauchet, LD La Rochelle, O Hermine, S Guidez, P Cony-Makhoul, P Fogarty, S Le Gouill, F Morschhauser, T Gastinne, G Cartron, M Subklewe, FL Locke, R Sanderson, P Barba, R Houot, E Bachy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading